Macerich Declares the Quarterly Dividend on Its Common Shares SANTA MONICA, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $.17 per share of common stock. The dividend is payable on June 3, 2024, to stockholders of record at the close of business on May 20, 2024. About Macerich Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractive U...
Macerich Celebrates Earth Month With ‘You Pledge We Plant’ Campaign, Industry Recognition Campaign To Plant 100,000+ Trees to Support Reforestation, Urban Forestry Retail REIT Named Green Lease Leader, Honored Among ‘America’s Most Responsible Companies’ SANTA MONICA, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation’s leading owners, operators and developers of high-quality retail real estate in top markets, is celebrating Earth Month with its “You Pledge We Plant” campaign to plant more than 100,000 trees across the country. In partnership with , Maceric...
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, . Once registered, a dial-i...
WICHITA, Kan.--(BUSINESS WIRE)-- Equity Bancshares, Inc. (NYSE: EQBK) (“Equity” or the “Company”), the Wichita-based holding company of Equity Bank, announced today its entry into a definitive merger agreement with KansasLand Bancshares Inc. (“KansasLand”), the parent company of KansasLand Bank in Quinter and Americus, Kansas, adding two locations to Equity Bank’s current network. Equity has one bank in Quinter, and two locations in Topeka, northeast of Americus. “We are proud to work with KansasLand Bank to add two new Equity locations in our home state of Kansas,” said Brad Elliott, Equity...
WICHITA, Kan.--(BUSINESS WIRE)-- Equity Bancshares, Inc. (NYSE: EQBK), (“Equity”, “the Company”, “we,” “us,” “our”), the Wichita-based holding company of Equity Bank, reported net income of $14.1 million or $0.90 earnings per diluted share for the quarter ended March 31, 2024. “Our Company entered the year positioned to take advantage of opportunities which we expect will drive our operating growth in the future,” said Brad S. Elliott, Chairman and CEO of Equity. “With our team’s proven, strategic skillset and cultivated relationships within our banking community, we were able to complete ou...
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th DENVER, April 16, 2024 (GLOBE NEWSWIRE) -- After the close of market trading on Tuesday, May 7, 2024, Angi Inc. (NASDAQ: ANGI) will post its first quarter results at . On Wednesday May 8, 2024, at 8:30 a.m. ET, Angi Inc. and IAC will host a conference call to answer questions regarding the companies’ respective first quarter results. The live audiocast and replay will be open to the public through the investor relations section of the Angi site at . About Angi Inc. Angi (NASDAQ: ANGI) helps...
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting AXS-05 in Alzheimer’s disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting effects of solriamfetol NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced present...
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6 NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it will report its financial results for the first quarter of 2024 on Monday, May 6, 2024, before the opening of the U.S. financial markets. Axsome’s management team will host a conference call at 8:00 a.m. Eastern Time on May 6, 2024, to discuss these results and provide a business ...
Angi Appoints Jeff Kip as CEO DENVER, April 08, 2024 (GLOBE NEWSWIRE) -- Angi (NASDAQ: ANGI), the leading and most comprehensive solution for all home care needs, today announced the appointment of Angi President and long-time IAC and Angi executive Jeff Kip to CEO, succeeding Joey Levin. As CEO, Mr. Kip will lead Angi’s executive team, overseeing strategy and daily management of the company. Mr. Levin, CEO of IAC, will continue as Chairman of the Angi Board of Directors. All changes are effective immediately. “Through multiple roles, Jeff Kip has been a student of the Angi business, fir...
Macerich Schedules First Quarter 2024 Earnings Release and Conference Call SANTA MONICA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules First Quarter 2024 Earnings Release and Conference Call WHEN: Earnings Results will be released before market open on Tuesday, April 30, 2024. Management will hold a conference call at 10:00 am Pacific Time (1:00 pm Eastern Time) on that same day to discuss quarterly results. WHERE: Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-in numb...
Occidental to Announce First Quarter Results Tuesday, May 7, 2024; Hold Conference Call Wednesday, May 8, 2024 HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) -- (NYSE: OXY) will announce its first quarter 2024 financial results after close of market on Tuesday, May 7, 2024, and will hold a conference call to discuss results on Wednesday, May 8, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at Participants may pre-register for the conference call at . First quarter 2024 financi...
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced the initiation of the ENGAGE Phase 3 trial of solriamfetol, an investigational treatment for binge eating disorder (BED) in adults. ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomi...
A director at Macerich Co sold 95,000 shares at 17.152USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
A director at Texas Pacific Land Corp bought 12 shares at 1,679.180USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
WICHITA, Kan.--(BUSINESS WIRE)-- Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its first quarter results on Tuesday, April 16, 2024, with a press release issued after market close. Equity Chairman and Chief Executive Officer Brad Elliott and Chief Financial Officer Chris Navratil will hold a conference call and webcast to discuss earnings results on Wednesday, April 17, 2024 at 10 a.m. eastern time or 9 a.m. central time. A live webcast of the call will be available on the Company’s website at . To access the call by phone, ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.